Ascletis Announces Submission of Marketing Authorization Application for Ritonavir in Hong Kong ...Middle East

HANGZHOU and SHAOXING, China, April 3, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the Hong Kong Special Administrative Region of the People's Republic of...

Read More Details
Finally We wish PressBee provided you with enough information of ( Ascletis Announces Submission of Marketing Authorization Application for Ritonavir in Hong Kong )

Also on site :

• Country 'MVP' Refunds Entire Audience Mid-Concert and Fans 'Cannot Believe He Did That'
• With Property Seized and Federal Funding Uncertain, Montana Asbestos Clinic Fights for Its Life
• Trump fija nuevo plazo de negociación de dos semanas y desencadena esfuerzo urgente por reanudar las conversaciones con Irán